Tüdőrák: vizsgálatok itt: Szingapúr
2 of 43 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseTaking peopleOsimertinib for Advanced EGFR-positive NSCLC Patients
- Where
- Singapore
- Életkor
- 21 év to 99 év
- People
- 58
- Run by
- National University Hospital, Singapore
See details and how to joinNCT05037331 - No phaseTaking peopleA Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC
- Where
- Singapore
- Életkor
- 21 év to 99 év
- People
- 600 worldwide
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT06418412